生物制剂-话题@MedSci

#生物制剂#

122篇内容 | 3953人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1825997, encodeId=ec78182599ee4, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险, objectType=article, longId=162333, objectId=0fa216233337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fa216233337, replyNumber=0, likeNumber=56, createdTime=2019-08-09, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fa216233337, moduleTitle=Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fa216233337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825996, encodeId=ca13182599672, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=J Rheumatol：使用生物制剂治疗银屑病关节炎的指炎和附着点炎, objectType=article, longId=161850, objectId=40901618500d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40901618500d, replyNumber=0, likeNumber=57, createdTime=2020-02-11, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40901618500d, moduleTitle=J Rheumatol：使用生物制剂治疗银屑病关节炎的指炎和附着点炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40901618500d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825989, encodeId=90c718259897e, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂治疗系统性红斑狼疮面面观, objectType=article, longId=146561, objectId=461e14656184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=461e14656184, replyNumber=0, likeNumber=62, createdTime=2019-07-26, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=461e14656184, moduleTitle=生物制剂治疗系统性红斑狼疮面面观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=461e14656184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825992, encodeId=08e21825992c1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2019 奥地利共识：孕期和哺乳期免疫抑制剂和生物制剂的应用, objectType=article, longId=158615, objectId=da1d158615be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da1d158615be, replyNumber=0, likeNumber=31, createdTime=2019-06-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da1d158615be, moduleTitle=2019 奥地利共识：孕期和哺乳期免疫抑制剂和生物制剂的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da1d158615be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825979, encodeId=e54718259e9a1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, objectType=article, longId=132424, objectId=a7f51324240d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f51324240d, replyNumber=0, likeNumber=55, createdTime=2019-01-27, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f51324240d, moduleTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f51324240d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825982, encodeId=4fa218259825f, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Am J Gastroenterology：延长使用糖皮质激素相比于使用生物制剂对于IBD患者来说更具有生命危险。, objectType=article, longId=134454, objectId=ae4a134454e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae4a134454e4, replyNumber=0, likeNumber=55, createdTime=2019-02-17, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae4a134454e4, moduleTitle=Am J Gastroenterology：延长使用糖皮质激素相比于使用生物制剂对于IBD患者来说更具有生命危险。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae4a134454e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825983, encodeId=d7c618259839c, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2018 NASPGHAN临床报告：确保儿童炎症性肠病非住院患者生物制剂输注质量, objectType=article, longId=136186, objectId=22c913618672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22c913618672, replyNumber=0, likeNumber=33, createdTime=2018-09-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22c913618672, moduleTitle=2018 NASPGHAN临床报告：确保儿童炎症性肠病非住院患者生物制剂输注质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22c913618672)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825988, encodeId=16c9182598825, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Intern Med J：生物制剂对类风湿性关节炎治疗的真实世界研究, objectType=article, longId=146105, objectId=c9901461054e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9901461054e, replyNumber=0, likeNumber=60, createdTime=2018-12-24, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9901461054e, moduleTitle=Intern Med J：生物制剂对类风湿性关节炎治疗的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9901461054e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825985, encodeId=8e941825985e6, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=BMJ：很多新药和生物制剂上市后未按照FDA要求完善信息！, objectType=article, longId=142639, objectId=9c81142639bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c81142639bf, replyNumber=0, likeNumber=53, createdTime=2018-09-01, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c81142639bf, moduleTitle=BMJ：很多新药和生物制剂上市后未按照FDA要求完善信息！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c81142639bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825990, encodeId=2602182599069, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2018 AAOS/NIH U-13会议共识建议：优化骨科手术中生物制剂的应用, objectType=article, longId=151044, objectId=a6c915104470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6c915104470, replyNumber=0, likeNumber=0, createdTime=2018-12-25, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6c915104470, moduleTitle=2018 AAOS/NIH U-13会议共识建议：优化骨科手术中生物制剂的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6c915104470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825977, encodeId=537018259e788, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：孕前或孕期使用生物制剂治疗自身免疫性疾病出现早产和小于胎龄儿的风险, objectType=article, longId=131433, objectId=57971314334d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57971314334d, replyNumber=0, likeNumber=86, createdTime=2019-01-01, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57971314334d, moduleTitle=Ann Rheum Dis：孕前或孕期使用生物制剂治疗自身免疫性疾病出现早产和小于胎龄儿的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57971314334d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825974, encodeId=5fc118259e4c1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：患者特征影响RA生物性药物的选择，并使非TNFi生物制剂显得比TNFi生物制剂更有害, objectType=article, longId=123567, objectId=bac512356e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bac512356e55, replyNumber=0, likeNumber=59, createdTime=2018-05-10, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bac512356e55, moduleTitle=Ann Rheum Dis：患者特征影响RA生物性药物的选择，并使非TNFi生物制剂显得比TNFi生物制剂更有害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bac512356e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825980, encodeId=951e182598054, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=JCC：炎症性肠病患者的癌症风险与年龄和近期使用免疫调节剂有关，而生物制剂和氨基水杨酸盐是保护性因素。, objectType=article, longId=132894, objectId=8b0e1328946b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b0e1328946b, replyNumber=0, likeNumber=55, createdTime=2019-01-19, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b0e1328946b, moduleTitle=JCC：炎症性肠病患者的癌症风险与年龄和近期使用免疫调节剂有关，而生物制剂和氨基水杨酸盐是保护性因素。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b0e1328946b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825972, encodeId=16c818259e23e, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=JCC：CD患者一定要慎重停用生物制剂！, objectType=article, longId=123049, objectId=dbed123049f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbed123049f9, replyNumber=0, likeNumber=58, createdTime=2018-01-18, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbed123049f9, moduleTitle=JCC：CD患者一定要慎重停用生物制剂！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbed123049f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825987, encodeId=f235182598e74, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Semin Arthritis Rheu：生物制剂在老年类风湿性关节炎患者中的疗效和安全性, objectType=article, longId=146096, objectId=d7ec14609633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7ec14609633, replyNumber=0, likeNumber=67, createdTime=2019-01-30, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7ec14609633, moduleTitle=Semin Arthritis Rheu：生物制剂在老年类风湿性关节炎患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7ec14609633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825971, encodeId=b8da18259e1ed, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=英国推出Janssen的新型银屑病生物制剂Tremfya, objectType=article, longId=121472, objectId=ec8c1214e24c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec8c1214e24c, replyNumber=0, likeNumber=51, createdTime=2018-04-30, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec8c1214e24c, moduleTitle=英国推出Janssen的新型银屑病生物制剂Tremfya, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec8c1214e24c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825978, encodeId=135418259e8ea, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Aliment Pharm Therap:中度至重度溃疡性结肠炎：托法替布vs生物制剂, objectType=article, longId=131750, objectId=cb93131e509e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb93131e509e, replyNumber=0, likeNumber=81, createdTime=2019-01-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb93131e509e, moduleTitle=Aliment Pharm Therap:中度至重度溃疡性结肠炎：托法替布vs生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb93131e509e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825973, encodeId=d2e618259e305, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=FDA批准了葛兰素史克的用于治疗罕见自身免疫性疾病的生物制剂, objectType=article, longId=123375, objectId=cf7e1233e57b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf7e1233e57b, replyNumber=0, likeNumber=73, createdTime=2018-01-08, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf7e1233e57b, moduleTitle=FDA批准了葛兰素史克的用于治疗罕见自身免疫性疾病的生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf7e1233e57b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825986, encodeId=95af182598619, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=患者报告结局相比客观炎性标记物对生物制剂治疗RA患者病假的影响更为重要, objectType=article, longId=144553, objectId=3957144553e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3957144553e4, replyNumber=0, likeNumber=62, createdTime=2019-03-12, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3957144553e4, moduleTitle=患者报告结局相比客观炎性标记物对生物制剂治疗RA患者病假的影响更为重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3957144553e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825970, encodeId=098e18259e0d5, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=J Rheumatol：生物制剂联合狄诺塞麦治疗类风湿关节炎的重症感染发生率, objectType=article, longId=120959, objectId=02061209599e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02061209599e, replyNumber=0, likeNumber=67, createdTime=2018-05-07, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02061209599e, moduleTitle=J Rheumatol：生物制剂联合狄诺塞麦治疗类风湿关节炎的重症感染发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02061209599e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物制剂

2020-05-29发表于威斯康星

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险

2019-08-09

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

J Rheumatol：使用生物制剂治疗银屑病关节炎的指炎和附着点炎

2020-02-11

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

生物制剂治疗系统性红斑狼疮面面观

2019-07-26

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2019 奥地利共识：孕期和哺乳期免疫抑制剂和生物制剂的应用

2019-06-21

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性

2019-01-27

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Am J Gastroenterology：延长使用糖皮质激素相比于使用生物制剂对于IBD患者来说更具有生命危险。

2019-02-17

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2018 NASPGHAN临床报告：确保儿童炎症性肠病非住院患者生物制剂输注质量

2018-09-28

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Intern Med J：生物制剂对类风湿性关节炎治疗的真实世界研究

2018-12-24

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

BMJ：很多新药和生物制剂上市后未按照FDA要求完善信息！

2018-09-01

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2018 AAOS/NIH U-13会议共识建议：优化骨科手术中生物制剂的应用

2018-12-25

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：孕前或孕期使用生物制剂治疗自身免疫性疾病出现早产和小于胎龄儿的风险

2019-01-01

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：患者特征影响RA生物性药物的选择，并使非TNFi生物制剂显得比TNFi生物制剂更有害

2018-05-10

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

JCC：炎症性肠病患者的癌症风险与年龄和近期使用免疫调节剂有关，而生物制剂和氨基水杨酸盐是保护性因素。

2019-01-19

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

JCC：CD患者一定要慎重停用生物制剂！

2018-01-18

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Semin Arthritis Rheu：生物制剂在老年类风湿性关节炎患者中的疗效和安全性

2019-01-30

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

英国推出Janssen的新型银屑病生物制剂Tremfya

2018-04-30

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Aliment Pharm Therap:中度至重度溃疡性结肠炎：托法替布vs生物制剂

2019-01-28

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

FDA批准了葛兰素史克的用于治疗罕见自身免疫性疾病的生物制剂

2018-01-08

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

患者报告结局相比客观炎性标记物对生物制剂治疗RA患者病假的影响更为重要

2019-03-12

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

J Rheumatol：生物制剂联合狄诺塞麦治疗类风湿关节炎的重症感染发生率

2018-05-07

科室
- - 订阅+
  - 更多科室
工具
服务